SEC Form 4 · accession 0001078782-16-002677
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Bradley Terrell M.D.
Officer — Chief Medical Officer
Period of report
Apr 15, 2016
Accepted (ET)
Apr 19, 2016 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.00 | Apr 15, 2016 | A | 25,000 | A | Apr 15, 2017 | Apr 15, 2022 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1A total of 25,000 Options were granted on April 15, 2016 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.